List of works - Reinhard Stauder

10th anniversary of the Austrian MDS Platform: aims and ongoing projects.

scientific article published on 25 November 2014

A phase I study of lenalidomide in patients with chronic myelomonocytic leukemia (CMML) - AGMT_CMML-1.

scientific article published on 30 August 2017

Aging and blood disorders: new perspectives, new challenges

scientific article published on April 2015

Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel

scientific article published on 17 January 2017

Anemia at older age: etiologies, clinical implications and management

scientific article published on 15 November 2017

Anemia in the elderly: clinical implications and new therapeutic concepts

scientific article

Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group

scientific article

Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications

scientific article published on 16 April 2016

Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group

scientific article

Azacitidine in CMML: matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival

scientific article published on 18 January 2014

Azacitidine in patients with WHO-defined AML – Results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group ⬇️

scientific article published on April 29, 2013

Cancer and ageism

scientific article

Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study.

scientific article published on 14 April 2017

Clinical, Hematologic, Biologic and Molecular Characteristics of Patients with Myeloproliferative Neoplasms and a Chronic Myelomonocytic Leukemia-Like Phenotype

scientific article published on 14 July 2020

Coalesced Multicentric Analysis of 2,351 Patients With Myelodysplastic Syndromes Indicates an Underestimation of Poor-Risk Cytogenetics of Myelodysplastic Syndromes in the International Prognostic Scoring System ⬇️

scientific article published on April 25, 2011

Complete remission after a single cycle of azacitidine in a case of relapsed acute myeloid leukemia ⬇️

scientific article published on January 5, 2013

Correlation of RAS-Pathway Mutations and Spontaneous Myeloid Colony Growth with Progression and Transformation in Chronic Myelomonocytic Leukemia-A Retrospective Analysis in 337 Patients

scientific article published on 24 April 2020

Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance

scientific article

Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes

scientific article published on 17 August 2016

Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference

scientific article published on 25 January 2007

Development of a core outcome set for myelodysplastic syndromes - a Delphi study from the EUMDS Registry Group

scientific article published on 14 May 2020

Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

scientific article published on 26 August 2013

Differing clinical features between Japanese and Caucasian patients with myelodysplastic syndromes: Analysis from the International Working Group for Prognosis of MDS

scientific article published on 06 September 2018

Diffuse large B-cell lymphoma in the elderly: impact of prognosis, comorbidities, geriatric assessment, and supportive care on clinical practice. An International Society of Geriatric Oncology (SIOG) expert position paper.

scientific article published on 07 December 2014

Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia

scientific article published on 30 January 2018

Exclusion of older patients from ongoing clinical trials for hematological malignancies: an evaluation of the National Institutes of Health Clinical Trial Registry

scientific article

Frequency of del(12p) is commonly underestimated in myelodysplastic syndromes: Results from a German diagnostic study in comparison with an international control group

scientific article published on 10 September 2015

Geriatric assessment of patients with hematological neoplasms

scientific article published on 31 March 2017

Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study

scientific article published on 6 March 2018

Hepatosplenic gammadelta-T-cell lymphoma with leukemic course after renal transplantation

scientific article published in February 2002

Impact of age and comorbidity in myelodysplastic syndromes

scientific article published on October 2008

Individualized management and therapy of myelodysplastic syndromes

scientific article

Molecular Basis and Clinical Application of Growth-Factor-Independent In Vitro Myeloid Colony Formation in Chronic Myelomonocytic Leukemia

scientific article published on 22 August 2020

Myelodysplastic Syndromes in the Elderly: Treatment Options and Personalized Management

scientific article

Myelodysplastic syndromes, aging, and age: correlations, common mechanisms, and clinical implications.

scientific article published on October 2007

New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge ⬇️

scientific article published on February 13, 2012

Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis

scientific article published in December 2005

Patient-reported outcome measures in studies of myelodysplastic syndromes and acute myeloid leukemia: Literature review and landscape analysis

scientific article published on 27 January 2020

Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes

scientific article published on 12 December 2017

Prevalence and possible causes of anemia in the elderly: a cross-sectional analysis of a large European university hospital cohort

scientific article

Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes

scientific article

Prognostic impact of a suboptimal number of analyzed metaphases in normal karyotype lower-risk MDS.

scientific article

Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study

scientific article published on 21 September 2015

Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions

scientific article published on 5 July 2017

Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score: results from the expanded international E-ALMA series (E-ALMA+).

scientific article published on 24 August 2017

Revised international prognostic scoring system for myelodysplastic syndromes

scientific article

Routine use of bendamustine and rituximab combination therapy in consecutive patients with lymphoproliferative diseases: A survey from Tyrolean hospitals ⬇️

scientific article published on April 13, 2011

Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a phase II study (AML-15) of the EORTC and GIMEMA leukemia groups.

scientific article published in August 2004

The challenge of individualised risk assessment and therapy planning in elderly high-risk myelodysplastic syndromes (MDS) patients

scientific article

Thromboembolic events in patients with myelodysplastic syndrome receiving thalidomide in combination with darbepoietin-alpha

scientific article published in April 2003

Time-dependent changes in mortality and transformation risk in MDS.

scientific article published on 22 June 2016

Validation of cytogenetic risk groups according to International Prognostic Scoring Systems by peripheral blood CD34+FISH: results from a German diagnostic study in comparison with an international control group

scientific article published on 24 October 2014

Validation of the revised international prognostic scoring system (IPSS-R) in patients with lower-risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registry.

scientific article

List of works by Reinhard Stauder

10th anniversary of the Austrian MDS Platform: aims and ongoing projects.

A phase I study of lenalidomide in patients with chronic myelomonocytic leukemia (CMML) - AGMT_CMML-1.

Aging and blood disorders: new perspectives, new challenges

Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel

Anemia at older age: etiologies, clinical implications and management

Anemia in the elderly: clinical implications and new therapeutic concepts

Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group

Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications

Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group

Azacitidine in CMML: matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival

Azacitidine in patients with WHO-defined AML – Results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group ⬇️

Cancer and ageism

Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study.

Clinical, Hematologic, Biologic and Molecular Characteristics of Patients with Myeloproliferative Neoplasms and a Chronic Myelomonocytic Leukemia-Like Phenotype

Coalesced Multicentric Analysis of 2,351 Patients With Myelodysplastic Syndromes Indicates an Underestimation of Poor-Risk Cytogenetics of Myelodysplastic Syndromes in the International Prognostic Scoring System ⬇️

Complete remission after a single cycle of azacitidine in a case of relapsed acute myeloid leukemia ⬇️

Correlation of RAS-Pathway Mutations and Spontaneous Myeloid Colony Growth with Progression and Transformation in Chronic Myelomonocytic Leukemia-A Retrospective Analysis in 337 Patients

Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance

Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes

Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference

Development of a core outcome set for myelodysplastic syndromes - a Delphi study from the EUMDS Registry Group

Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

Differing clinical features between Japanese and Caucasian patients with myelodysplastic syndromes: Analysis from the International Working Group for Prognosis of MDS

Diffuse large B-cell lymphoma in the elderly: impact of prognosis, comorbidities, geriatric assessment, and supportive care on clinical practice. An International Society of Geriatric Oncology (SIOG) expert position paper.

Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia

Exclusion of older patients from ongoing clinical trials for hematological malignancies: an evaluation of the National Institutes of Health Clinical Trial Registry

Frequency of del(12p) is commonly underestimated in myelodysplastic syndromes: Results from a German diagnostic study in comparison with an international control group

Geriatric assessment of patients with hematological neoplasms

Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study

Hepatosplenic gammadelta-T-cell lymphoma with leukemic course after renal transplantation

Impact of age and comorbidity in myelodysplastic syndromes

Individualized management and therapy of myelodysplastic syndromes

Molecular Basis and Clinical Application of Growth-Factor-Independent In Vitro Myeloid Colony Formation in Chronic Myelomonocytic Leukemia

Myelodysplastic Syndromes in the Elderly: Treatment Options and Personalized Management

Myelodysplastic syndromes, aging, and age: correlations, common mechanisms, and clinical implications.

New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge ⬇️

Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis

Patient-reported outcome measures in studies of myelodysplastic syndromes and acute myeloid leukemia: Literature review and landscape analysis

Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes

Prevalence and possible causes of anemia in the elderly: a cross-sectional analysis of a large European university hospital cohort

Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes

Prognostic impact of a suboptimal number of analyzed metaphases in normal karyotype lower-risk MDS.

Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study

Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions

Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score: results from the expanded international E-ALMA series (E-ALMA+).

Revised international prognostic scoring system for myelodysplastic syndromes

Routine use of bendamustine and rituximab combination therapy in consecutive patients with lymphoproliferative diseases: A survey from Tyrolean hospitals ⬇️

Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a phase II study (AML-15) of the EORTC and GIMEMA leukemia groups.

The challenge of individualised risk assessment and therapy planning in elderly high-risk myelodysplastic syndromes (MDS) patients

Thromboembolic events in patients with myelodysplastic syndrome receiving thalidomide in combination with darbepoietin-alpha

Time-dependent changes in mortality and transformation risk in MDS.

Validation of cytogenetic risk groups according to International Prognostic Scoring Systems by peripheral blood CD34+FISH: results from a German diagnostic study in comparison with an international control group

Validation of the revised international prognostic scoring system (IPSS-R) in patients with lower-risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registry.